Analytical Data
-
Gene name
FAM102A
- Application
-
Alternative Names
FAM102A; C9orf132; EEIG1; Protein FAM102A; Early estrogen-induced gene 1 protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5T9C2
-
Expression Region
1-242aa
-
AA Sequence
MFLLSGDPCFKTPPSTAKSISIPGQDSSLQLTCKGGGTSSGGSSTNSLTGSRPPKARPTILSSGLPEEPDQNLSSPEEVFHSGHSRNSSYASQQSKISGYSTEHSRSSSLSDLTHRRNTSTSSSASGGLGMTVEGPEGSEREHRPPEKPPRPPRPLHLSDRSFRRKKDSVESHPTWVDDTRIDADAIVEKIVQSQDFTDGSNTEDSNLRLFVSRDGSATLSGIQLATRVSSGVYEPVVIESH
-
Molecular Weight
52.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM102A, a member of the FAM (Family with Sequence Similarity) protein family, has garnered attention in recent years due to its potential roles in cellular processes and disease mechanisms. This protein is characterized by its presence in various tissues and its involvement in critical pathways, including cell proliferation, differentiation, and apoptosis. Research has suggested that FAM102A may play a significant role in cellular stress responses and has been linked to several diseases, including cancer and neurodegenerative disorders. The study of FAM102A recombinant proteins aims to elucidate the functional properties of this protein, providing insights into its biological roles and interactions. Understanding FAM102A's structure and function through recombinant expression systems could pave the way for developing therapeutic strategies targeting related pathways. Additionally, the exploration of FAM102A may uncover novel biomarkers for disease diagnosis and prognosis, highlighting its relevance in translational research and therapeutic innovations. As the scientific community continues to investigate the multifaceted roles of FAM102A, it remains an intriguing subject for further exploration in the realms of molecular biology and medicine.
